ERBB2 and breast carcinoma: The use of PVX nanocarriers for Herceptin delivery in breast cancer treatment has shown enhanced therapeutic efficacy, as it effectively induces apoptosis in HER2 positive cell lines, demonstrating the potential of this innovative approach [319].